Anchyra Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57M Buy
10,791
+1,045
+11% +$144K 0.33% 57
2026
Q2
$1.25M Buy
9,746
+535
+6% +$62.6K 0.3% 66
2026
Q1
$1.11M Buy
9,211
+404
+5% +$46.6K 0.34% 62
2025
Q4
$927K Buy
+8,807
New +$827K 0.28% 74

Other funds holding MRK

Anchyra Partners's MRK Position: Q3 2026 in Review

Anchyra Partners increased its Merck (MRK) stake by 11% in Q3 2026, buying an estimated $144K and bringing the position to 10,791 shares worth $1.57M. The position accounts for 0.33% of the portfolio, ranked #57.

Anchyra Partners first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Anchyra Partners held 10,791 shares of Merck worth $1.57M as of Q3 2026.
  • Anchyra Partners bought 1,045 Merck shares in Q3 2026, an estimated $144K.
  • Merck made up 0.33% of Anchyra Partners's portfolio in Q3 2026, its #57 holding.
  • Anchyra Partners first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.